Breaks Categories: Stock Spotlights

WednesdayMar 09, 2022 2:21 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) in the Driver’s Seat Across One of the Country’s Largest, Fastest-Growing Cannabis Markets

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently announced it had received all regulatory approvals and closed its acquisition of PharmaCo, a Michigan-based marijuana company. This acquisition expands RWB’s footprint within the state, having initially only had a single product line in this market – the Platinum Vape(R) brand. Following the acquisition, RWB now controls all aspects of its Michigan operations. “This successful acquisition gives RWB access to 22 owned properties, including nine dispensaries and three cultivation sites in Glendale, Marquette and Au Gres… Going forward, RWB looks to execute its initiatives that include extending its branded product…

Continue Reading

FridayMar 04, 2022 2:15 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) On Path Toward Improved Margins Through Vertical Integration

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a cannabis and CBD product brand builder with a presence in California, Arizona, Oklahoma, Illinois, Michigan, and Florida, most recently celebrated the news that Michigan had granted it adult recreational use prequalification status for manufacture, followed by full licensing to make both medical and adult-use cannabis products in the state. “The company’s lease assignment for a 15,000-square-foot manufacturing and processing facility in the city of Warren led to the launch of operations there [in January], with ‘all necessary equipment already installed and inspections completed’ for medical and adult-use products,” a recent…

Continue Reading

ThursdayMar 03, 2022 3:02 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Portfolio, Presence in Growing Rare Cannabinoid Market

InMed Pharmaceuticals (NASDAQ: INM) is uniquely positioned to leverage the growing worldwide awareness of the potential of cannabinoids and the rising demand for rare cannabinoids. The company has begun this year on a high, following the 2021 acquisition of BayMedica and the launch of cannabicitran (“CBT”) sales. “With the launch of business-to-business sales of CBT in the health and wellness sector, InMed has further expanded its portfolio and its presence in the growing rare cannabinoid market,” reports a recent article. “CBT is the first of several new products InMed is planning to launch in the first half of 2022 in…

Continue Reading

ThursdayMar 03, 2022 2:44 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Faster, Higher Overall Delivery of Sildenafil into Bloodstream

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released positive results from an animal study that evaluated DehydraTECH(TM) processing of the phosphodiesterase inhibitor (“PDE5 inhibitor”) sildenafil as potential use in the management of erectile dysfunction. “A clear trend emerged during the course of the study – a faster and higher overall delivery of sildenafil into the bloodstream. During the animal study, it was determined that in as little as four minutes of dosing, the DehydraTECH formulation of sildenafil delivered 74% more of the PDE5 inhibitor into the bloodstream on average than the concentration-matched, generic control formulation. Within seven minutes, the DehydraTECH-sildenafil formulation…

Continue Reading

MondayFeb 28, 2022 2:50 pm

CannabisNewsBreaks – American Cannabis Partners Standing Distinct Thanks to Sustainable Practices, Strategic Positioning

American Cannabis Partners (“ACP”), a Jamaican experience canna-business innovator, is committed to doing its part as the sustainability trend permeates all sectors, including cannabis. Sustainability is a growing priority for businesses in today’s environment-conscious and energy-aware world. A recent article notes that the advantages of sustainability are twofold: making a positive impact on the environment and connecting with consumers who are becoming increasingly aware and supportive of companies working to make a difference. “ACP follows an organic cultivation model that includes implementing sustainable operating practices designed to reduce the company’s environmental footprint and increase its social responsibility,” the article reads.…

Continue Reading

FridayFeb 25, 2022 1:35 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Optimistic of Positive Study Results, Eyes ‘Most Exciting Year Ever’

Lexaria Bioscience Corp. (NASDAQ: LEXX) achieved myriad milestones in 2021, with CEO Chris Bunka noting in an annual letter to shareholders that January 2021 marked the birth of a modern version of the company. A recent article contains excerpts from the letter, in which Bunka writes, “During 2021, we completed research & development (‘R&D’) and validating work equal to or greater than all the combined amount previously completed since 2018! We have conducted studies across broad areas of interest but also concentrated in specific areas where we have supportive data,” In 2021, Lexaria’s most significant area of investigation was DehydraTECH(TM)-processed…

Continue Reading

FridayFeb 18, 2022 1:58 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Is World Leader Through DehydraTECH(TM) – Its Pioneering Drug Delivery Technology

Lexaria Bioscience Corp. (NASDAQ: LEXX) commented on an independent study headed by lead research scientist Dr. Richard van Breeman, which discovered that cannabinoids can block cellular entry of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its emerging variants. The study showed that smoking and vaping are likely ineffective measures, whereas oral delivery methods are. “As a company, Lexaria is already actively exploring and researching DehydraTECH(TM)-enabled cannabinoid formulations across various potential therapeutic applications, including oral formulations that are being prepared for registered clinical trials as a possible new pharmaceutical product,” reads a recent article. “In response to the study, Chris…

Continue Reading

ThursdayFeb 17, 2022 3:02 pm

CannabisNewsBreaks – American Cannabis Partners Leveraging Multi-Sectoral Positioning to Tap into Growing Market

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator, is positioning itself to benefit from the projected growth in the legal cannabis market. “‘Sales from cannabis were $20 billion in 2020 and are expected to exceed $26 billion in 2021. Research conducted by Cowen and Company reveals the legal cannabis market is bound to grow 20-30% per year to the price of $50 billion by 2026,’” reads a recent article quoting a Forbes report. Separately, and as noted by CNN Business, the cannabis industry in America is flourishing; “‘Sales hit $20 billion in 2020 and are on pace to…

Continue Reading

WednesdayFeb 16, 2022 3:24 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc.’s (CSE: RWB) (OTCQX: RWBYF) Warren Facility Providing Centralized Distribution, Production Capacity to Expand Sales

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) has received full licensing for manufacturing both medical and adult-use cannabis products in Michigan, a state entering its third year under legislation allowing the legal sale of adult recreational-use cannabis. In addition, a recent article notes, “The company has closed on a lease assignment for a 15,000-square-foot manufacturing, processing and distribution facility in Warren, Michigan, which is part of RWB’s strategic planned acquisition of 18 Michigan dispensaries, four cultivation facilities and other significant real estate announced in September.” RWB CEO and Chairman Brad Rogers comments: “This Warren facility allows us to…

Continue Reading

MondayFeb 14, 2022 2:28 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) in Unique Position to Offer Full Slate of Rare Cannabinoid Manufacturing Technologies

InMed Pharmaceuticals (NASDAQ: INM) understands the immense potential of rare cannabinoids and sees them as having applications as wide as cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”), variants of cannabinoids that make up most of the content in cannabis plants. Studies suggest that rare cannabinoids could offer more potent medical benefits than CBD and without the psychoactive attribute of THC, representing a huge market. “However, the industry wide problem has always been to obtain the production scales necessary for cost-effective commercialization of such compounds, while also ensuring the purity and consistency that can be difficult at even low volumes. The answer is…

Continue Reading